Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6M Buy
589,634
+9,303
+2% +$248K 0.16% 177
2025
Q4
$14.5M Buy
580,331
+17,027
+3% +$429K 0.14% 191
2025
Q3
$14.4M Sell
563,304
-107,937
-16% -$2.66M 0.14% 190
2025
Q2
$16.3M Sell
671,241
-122,695
-15% -$2.86M 0.16% 160
2025
Q1
$20.1M Buy
793,936
+28,572
+4% +$748K 0.22% 122
2024
Q4
$20.3M Buy
765,364
+87,621
+13% +$2.38M 0.21% 124
2024
Q3
$19.6M Buy
677,743
+97,078
+17% +$2.83M 0.2% 138
2024
Q2
$16.2M Buy
580,665
+47,414
+9% +$1.31M 0.18% 153
2024
Q1
$14.8M Buy
533,251
+295,139
+124% +$8.19M 0.15% 174
2023
Q4
$6.86M Buy
238,112
+84,907
+55% +$2.57M 0.07% 285
2023
Q3
$5.08M Sell
153,205
-595
-0.4% -$21K 0.06% 317
2023
Q2
$5.64M Sell
153,800
-3,816
-2% -$149K 0.06% 310
2023
Q1
$6.43M Sell
157,616
-7,143
-4% -$309K 0.07% 283
2022
Q4
$8.44M Sell
164,759
-14,070
-8% -$675K 0.09% 241
2022
Q3
$7.83M Sell
178,829
-21,746
-11% -$1.06M 0.09% 240
2022
Q2
$10.5M Buy
200,575
+7,877
+4% +$401K 0.12% 219
2022
Q1
$9.98M Sell
192,698
-2,929
-1% -$152K 0.09% 243
2021
Q4
$11.6M Sell
195,627
-9,591
-5% -$475K 0.1% 232
2021
Q3
$8.83M Sell
205,218
-6,134
-3% -$272K 0.08% 267
2021
Q2
$8.28M Buy
211,352
+19,397
+10% +$754K 0.07% 285
2021
Q1
$6.96M Sell
191,955
-6,023
-3% -$214K 0.06% 299
2020
Q4
$7.29M Sell
197,978
-30,537
-13% -$1.12M 0.07% 286
2020
Q3
$7.96M Sell
228,515
-20,068
-8% -$704K 0.09% 257
2020
Q2
$7.71M Sell
248,583
-70,973
-22% -$2.41M 0.09% 257
2020
Q1
$9.9M Buy
319,556
+44,345
+16% +$1.51M 0.12% 211
2019
Q4
$10.2M Sell
275,211
-24,572
-8% -$875K 0.08% 247
2019
Q3
$10.2M Sell
299,783
-8,883
-3% -$323K 0.09% 242
2019
Q2
$12.7M Sell
308,666
-10,371
-3% -$412K 0.1% 233
2019
Q1
$12.9M Sell
319,037
-7,209
-2% -$289K 0.1% 225
2018
Q4
$13.5M Sell
326,246
-11,889
-4% -$494K 0.11% 205
2018
Q3
$14.1M Sell
338,135
-22,734
-6% -$875K 0.1% 227
2018
Q2
$12.4M Sell
360,869
-47,557
-12% -$1.63M 0.08% 235
2018
Q1
$13.8M Buy
408,426
+1,549
+0.4% +$53.3K 0.09% 230
2017
Q4
$14M Sell
406,877
-96,014
-19% -$3.27M 0.09% 226
2017
Q3
$17M Sell
502,891
-7,623
-1% -$245K 0.11% 214
2017
Q2
$16.3M Sell
510,514
-1,167
-0.2% -$36.8K 0.1% 211
2017
Q1
$16.6M Sell
511,681
-5,251
-1% -$166K 0.11% 206
2016
Q4
$15.9M Sell
516,932
-12,583
-2% -$384K 0.1% 203
2016
Q3
$17M Sell
529,515
-16,395
-3% -$548K 0.11% 199
2016
Q2
$18.2M Sell
545,910
-20,100
-4% -$642K 0.12% 188
2016
Q1
$15.9M Sell
566,010
-179,122
-24% -$5.12M 0.11% 200
2015
Q4
$22.8M Sell
745,132
-24,293
-3% -$764K 0.15% 170
2015
Q3
$22.9M Sell
769,425
-94,751
-11% -$3.04M 0.15% 169
2015
Q2
$27.5M Sell
864,176
-80,662
-9% -$2.63M 0.15% 167
2015
Q1
$31.2M Sell
944,838
-58,130
-6% -$1.85M 0.16% 165
2014
Q4
$29.6M Sell
1,002,968
-75,886
-7% -$2.18M 0.15% 172
2014
Q3
$30.3M Sell
1,078,854
-84,836
-7% -$2.38M 0.16% 165
2014
Q2
$32.8M Sell
1,163,690
-64,825
-5% -$1.85M 0.17% 156
2014
Q1
$37.4M Sell
1,228,515
-19,150
-2% -$571K 0.2% 138
2013
Q4
$36.3M Sell
1,247,665
-20,132
-2% -$586K 0.19% 148
2013
Q3
$34.6M Buy
1,267,797
+158,685
+14% +$4.32M 0.2% 145
2013
Q2
$29.5M Buy
+1,109,112
New +$30.6M 0.19% 156

Other funds holding PFE

GAMCO Investors's PFE Position: Q1 2026 in Review

GAMCO Investors increased its Pfizer (PFE) stake by 1.6% in Q1 2026, buying an estimated $248K and bringing the position to 589,634 shares worth $16.6M. The position accounts for 0.16% of the portfolio, ranked #177.

GAMCO Investors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.4M in Q1 2014. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • GAMCO Investors held 589,634 shares of Pfizer worth $16.6M as of Q1 2026.
  • GAMCO Investors bought 9,303 Pfizer shares in Q1 2026, an estimated $248K.
  • Pfizer made up 0.16% of GAMCO Investors's portfolio in Q1 2026, its #177 holding.
  • GAMCO Investors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • GAMCO Investors's Pfizer position peaked at $37.4M in Q1 2014.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.